Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Noopept regulatory status

Current status of Noopept in the United States: Unscheduled. In sport: WADA status unclear. Details, sources, and the dated timeline follow.

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

What is the current status of Noopept?

Regulatory: UnscheduledWADA: WADA status unclearVerified: Verified Sep 29, 2026
FDA and compounding
Noopept is not an FDA approved drug and is not part of any approved drug. As of the last verification date it does not appear in any FDA 503A category or on the list of withdrawn nominations, and it is not on the 503A bulks list, so it is outside FDA's interim policy and a 503A pharmacy has no federal basis to compound it from bulk. It is not eligible for 503B outsourcing. FDA has issued warning letters treating noopept products sold online with health claims as unapproved new drugs. Products sold as supplements or research chemicals are not verified for identity or purity.
WADA
WADA status unclear
Access path
  1. Prescription product in Russia and some other former Soviet countries.
  2. Not an FDA approved drug and not compoundable in the United States.
  3. Sold online as an unapproved supplement ingredient; identity and purity are not verified.

Full Noopept page: evidence, dosing in the literature, and sources

How has the status of Noopept changed over time?

No dated regulatory event has been recorded for Noopept. That usually means no FDA, PCAC, Federal Register, or WADA action has named it specifically. Category-wide actions are listed on the tracker hub.

Sources

Numbered citations in the answers above point here, followed by the regulatory sources on record for Noopept and the source of each dated event.

  1. [1]FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2 list and withdrawn nominations, current as of April 22, 2026)FDA, 2026
  2. [2]FDA: Compounding and the FDA, questions and answersFDA, 2026
  3. [3]WADA Prohibited ListWADA, 2026